These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


559 related items for PubMed ID: 16885545

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A.
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Teaching clinicians about drugs--50 years later, whose job is it?
    Avorn J.
    N Engl J Med; 2011 Mar 31; 364(13):1185-7. PubMed ID: 21449781
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Practical, legal, and ethical issues in expanded access to investigational drugs.
    Darrow JJ, Sarpatwari A, Avorn J, Kesselheim AS.
    N Engl J Med; 2015 Jan 15; 372(3):279-86. PubMed ID: 25587952
    [No Abstract] [Full Text] [Related]

  • 8. Shifting terrain in the regulation of off-label promotion of pharmaceuticals.
    Mello MM, Studdert DM, Brennan TA.
    N Engl J Med; 2009 Apr 09; 360(15):1557-66. PubMed ID: 19357413
    [No Abstract] [Full Text] [Related]

  • 9. No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.
    Moss RW.
    New Sci; 2009 Apr 09; 190(2554):21. PubMed ID: 16832956
    [No Abstract] [Full Text] [Related]

  • 10. Drug development history, "overview," and what are GCPs?
    Heilman RD.
    Qual Assur; 1995 Mar 09; 4(1):75-9. PubMed ID: 8520867
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
    Purnhagen KP.
    Food Drug Law J; 2008 Mar 09; 63(3):623-45. PubMed ID: 19031663
    [No Abstract] [Full Text] [Related]

  • 16. US court rules to allow experimental drugs for dying patients.
    Waltz E.
    Nat Med; 2006 Jun 09; 12(6):596. PubMed ID: 16760988
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Learning about the safety of drugs--a half-century of evolution.
    Avorn J.
    N Engl J Med; 2011 Dec 08; 365(23):2151-3. PubMed ID: 22150034
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.